DSpace Repository

RELEVANCE OF DIAGNOSTICS AND TREATMENT OF BREAST CANCER IN MEN

Show simple item record

dc.contributor.author Fayziev F. Sh
dc.date.accessioned 2023-05-07T09:47:09Z
dc.date.available 2023-05-07T09:47:09Z
dc.date.issued 2023
dc.identifier.uri http://repository.tma.uz/xmlui/handle/1/7522
dc.description.abstract Breast cancer in men is a rare disease, accounting for approximately 0.1% of all malignant breast tumors in men and from 0.6% to 1% of all malignant breast tumors. The incidence of breast cancer in men increases with age for unknown reasons: the average age of men at the time of diagnosis is 67 years, compared with women, whose similar indicator is 57 years. Despite advances in the diagnostics and treatment of breast cancer in women, understanding and strategy for the treatment of breast cancer in men are limited and generally extrapolated from existing knowledge about breast cancer in women. In particular, the molecular subtypes of breast cancer in men have not been studied, although these subtypes have been associated with both biological and clinical features of breast cancer in women. It has been proven that molecular subtypes have an important prognostic value in breast cancer in women. Molecular assessment of tumors plays a significant role in the 22 prescriptions of adjuvant chemotherapy, and therefore the role of genetic testing increases en_US
dc.language.iso en_US en_US
dc.publisher Санкт-Петербург en_US
dc.subject breast cancer, gynecomastia, oncoepidemiology, hormone therapy en_US
dc.title RELEVANCE OF DIAGNOSTICS AND TREATMENT OF BREAST CANCER IN MEN en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account